Oncogenic activation of the KRAS gene occurs in >90% of pancreatic ductal carcinoma and malignant progression from pancreatic intraepithelial carcinoma to a more aggressive form of pancreatic cancer is accompanied by the early acquisition of KRAS oncogene activation (21,22). This evidence concerns the gene KRAS and pancreatic neoplasm.